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The Polytetrafluoroethylene (PTFE) Graft for Portacaval 
Interposition: An Experimental Observationt 
Alexander G. Yap, MD,* George Isshak, MD,* Ronald Lam, MD,** and Roger F. Smith, MD'' 
In an attempt to determine the efficacy of the poly-
tetrafluoroethylene (PTFE) graft as a portacaval interposi-
tion shunt, 26 mongrel dogs were randomly selected to 
receive a side-to-side shunt with a 6 mm, 8 mm, or 10 mm 
PTFE graft after portal hypertension had been created by 
hepatic vein ligation. The dogs were clinically observed, 
and if they showed signs of graft occlusion, they were re-
explored surgically. The 6 mm graft had aO% patency rate; 
the 8 mm graft had a 28.6% patency rate; and the 10 mm 
graft had an 87.5% patency rate. Histological examinations 
revealed adequate incorporation of the graft, formation of 
an endothelial layer, and absence of a thick intimal layer. 
In this experimental model, the PTFE graft served as a 
satisfactory portacaval interposition shunt when the 10 mm 
graft was used. 
r olytetrafluororethylene (PTFE) grafts have been exten-
sively used clinically during the last several years as arterial 
substitutes (1,2) and in isolated instances as venous sub-
stitutes (3-6). However, their use as venous substitutes has 
never been universally accepted because of the low pat-
ency rates, due primarily to the lower pressure and slower 
blood flow that characterizes the venous system. Drapanas 
and Lord have reported on their successful use of the teflon 
and dacron prosthesis for portacaval interposition shunts in 
cases of portal hypertension (7-11), and Rosenthal recently 
reported on the clinical use of the PTFE graft as a meso-
caval shunt in seven patients with portal hypertension (12). 
However, there are no published reports on the experi-
mental use of the PTFE graft as an interposition portacaval 
shunt for portal hypertension. Therefore, we decided to 
design an experimental animal model that would both 
create acute portal hypertension and test the effectiveness 
ofthe PTFE graft. We were also interested in evaluating the 
effect of different sizes of grafts on the adequacy of the 
portal decompression, the duration of the shunt patency, 
and the histological characteristics o f the implant. 
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Materials and Methods 
Twenty-six mongrel dogs of both sexes, weighing between 
19 and 29 kg, were anesthetized with sodium thiamylal for 
induction and halothane (0.1-1.5y2) for maintenance. 
Through a midline abdominal incision, the liver, portal 
vein, and inferior vena cava were exposed. The portal vein 
and inferior vena cava pressures were determined intra-
operatively so that normal base line values could be ob-
tained. The hepatic veins were carefully dissected and 
individually ligated using a technique similar to that de-
scribed by Orloff, et al (13-15). After the last hepatic vein 
had been ligated, the venous congestion of the liver and 
intestines was immediately evident. Creation of portal hy-
pertension was documented and recorded by measuring 
portal venous pressure directly (Fig. 1). 
The 26 dogs were then randomly assigned to four groups. 
Group I received a standard side-to-side portacaval shunt. 
Groups II, 111, and IV underwent a portacaval interposition 
shunt with 6 mm, 8 mm, and 10 mm PTFE grafts, respec-
tively. The length of the graft for all groups was kept 
constant at about 1.5 cm. The portal decompressing effect 
of the PTFE graft interposition shunt was measured by 
determining the postshunt portal venous pressure (Fig. 1). 
Postoperatively, the dogs were observed clinically on a 
daily basis. Serum bilirubin, alkaline phosphatase, serum 
glutamic-pyruvic transaminase (SGPT), and complete 
blood counts were obtained on a predetermined scheclule. 
The development of ascites was clinically assessed in all 
animals. Venograms were selectively taken to determine 
the patency of the graft. 
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CHANGE IN PORTAL PRESSURE FOLLOWING HEPATIC VEIN 
LIGATION AND INTERPOSITION PORTACAVAL SHUNT 
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Table I 
Group I 
Side-to-Side Shunt 
Normal Hepatic Vein PTFE Shunt 
Ligation 
Fig. 1 
Portal pressure increases wi th ligation of the hepatic veins and 
returns to normal after the PTFE interposition shunt. 
The dogs that survived the operation were randomly sacri-
ficed during the next ten months. Those that manifested 
signs of late graft thrombosis, such as ascites, were re-
explored. Three dogs were followed for at least ten months 
in order to evaluate the long-term patency and histological 
characteristics of the graft. All grafts were retrieved during 
the postmortem examinations and sent for microscopic 
pathological evaluation. 
Results 
Table I gives the results for the first group of dogs with side-
to-side portacaval shunts, which served as the control 
group. One dog died postoperatively within the first 24 
hours. The four remaining animals all had patent shunts up 
to a maximum period of five months of follow-up. 
In Group II, composed of dogs with 6 mm PTFE interposi-
tion shunts, all six PTFE grafts occluded during the first 24 
hours after surgery (Table II). At autopsy, severe liver and 
mesenteric venous congestion had resulted in scattered 
areas of intestinal ischemia and infarction. 
Among the seven dogs randomly assigned to the 8 mm 
PTFE group, two died on the first postoperative day (Table 
III). Again, the autopsy showed severe intestinal venous 
congestion with areas of bowel necrosis. The grafts were 
occluded. A third dog developed progressive ascites which 
started two weeks postoperat ively. This dog was re-
explored on the 21st postoperative day, and approximately 
4.5L of ascitic fluid was removed. The graft was collapsed 
and occluded. The liver was grossly congested, but there 
Dog Asc i tes 
Shunt 
Patency 
Follow-up 
(Weeks) 
Final 
Outcome 
1 None Open 8 Sacri f iced 
2 None Open 20 Sacri f iced 
3 None Closed < 1 day Died 
4 None Open 20 Sacr i f iced 
5 None Open 
Table II 
16 Sacr i f iced 
Group II 
6 mm Diameter P T F E Shunts 
Dog Asci tes 
Shunt 
Patency 
Foilow-up 
(Hours) 
Final 
Outcome 
1 None Occluded <12 Died 
2 None Occluded <12 Died 
3 None Occluded <12 Died 
4 None Occluded <12 Died 
5 None Occluded <12 Died 
6 None Occluded 
Table III 
<12 Died 
Group III 
8 mm Diameter P T F E Shunts 
Dogs Asci tes 
Shunt 
Patency 
Follow-up 
(Weeks) 
Final 
Outcome 
1 None Occluded 16 Sacri f iced 
2 None Occluded <1 day Died 
3 None Occluded < 1 day Died 
4 None Open 8 Sacri f iced 
5 Yes Occluded 3 Sacri f iced 
6 None Occ luded 27 Sacri f iced 
7 None Open 8 Sacri f iced 
were no signs of intestinal ischemia or necrosis. The portal 
pressure was elevated at 14 cmHjO. During the first opera-
tion on this dog the portal pressure was 16 cmHiO, but it 
had been reduced to 3 cmH20 after the shunt. Closure of 
the graft undoubtedly was responsible for the later increase 
in portal pressure from 3 to 14 cmHsO. 
Two other dogs were re-explored on the 60th and 67th 
postoperative day, and both were found to have an open 
graft. Two more dogs were followed for four and nine 
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Table IV 
Group IV 
10 mm Diameter PTFE Grants 
Shunt 
Dog Ascites Patency 
1 Yes Occluded 
2 None Open 
3 None Open 
4 None Open 
5 None Open 
6 None Open 
7 None Open 
8 None Open 
Follow-up 
(Weeks) 
Final 
Outcome 
8 Sacrificed 
14 Sacrificed 
44 Sacrificed 
.44 Sacrificed 
1 Died 
(Distemper) 
11 Sacrificed 
4 Sacrificed 
12 Sacrificed 
Fig. 2 
Venogram showing patent portacaval PTFE graft (10 mm) at 80 days 
after implantation. 
months, respectively. The grafts in both these dogs were 
found to be occluded on re-exploration, but no ascites or 
other signs of liver or intestinal congestion were found. 
In Group IV, none ofthe 10 mm grafts closed immediately, 
and none of the dogs died during the early postoperative 
period (Table IV). One dog developed ascites three weeks 
after the first operation. Abdominal paracentesis had to be 
performed twice to relieve the tense, enlarging abdomen 
before re-exploration on the 53rd postoperative day. The 
operative findings were similar to those found in the 8 mm 
graft dog with ascites: the graft was completely occluded. 
All other dogs with 10 mm PTFE grafts had open grafts. 
Venograms were performed selectively to demonstrate 
shunt patency (Fig. 2). 
When the grafts were recovered within four months or less, 
no significant gross changes were detectable. Microscopic 
examination revealed some red blood cells and a few 
monocytes and leukocytes within the wall. After the 90th 
postoperative day, microscopic examination revealed pro-
liferation of spindle-shaped fibroblasts and small blood 
vessels within the graft wall, as well as scattered mono-
nuclear cells of histiocytic origin with rare Langhan foreign 
body giant cells. All ten patent grafts were endothelialized 
with a layer of acquired fibrous intima of variable thick-
ness. One also showed microscopic foci of calcification. 
Afterthe fourth month of implantation, areas of patchy and 
extensive calcium depositions in the wall of the grafts were 
seen grossly and were more evident in the older grafts. The 
older grafts also appeared thick, hard, and gritty on cut 
sections. Microscopic examination revealed a more exten-
sive cellular reaction consisting of fibroblastic cells and 
endothelial proliferations with collagen and fibrous tissue 
deposited within the wall of the grafts. A single layer of flat 
endothelial cells (Fig. 3) was seen among the 10 mm grafts 
that were followed for up to ten months. None of the long-
Fig. 3 
Photomicrograph of 10 mm PTFE graft ten months after Implanta-
tion showing the endothelial layer (E), intimal layer (I), and calcifica-
tions (C). 72 X (H & E) 
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term grafts demonstrated any histologic evidence ofa thick 
pseudo-intimal layer. 
No significant changes in the serum bilirubin, alkaline 
phosphatase, or total serum protein became evident during 
the study. 
Discussion 
To carry out the aims of our study on PTFE grafts, it was 
necessary to develop an animal model of portal hyperten-
sion. This was accomplished by complete ligation of the 
hepatic veins, which, in turn, immediately resulted in 
severe hypertension in all dogs. During the same opera-
tion, the PTFE portacaval interposition was performed be-
cause the acute hypertension would lead to mesenteric 
thrombosis and death, as seen in the immediately closed 
grafts. This method also eliminated any morbidity associ-
ated w i th subject ing the animals to two separate 
operations. 
Immediate occlusion of the graft always led to early death, 
because the sudden increase of portal pressure without the 
decompressing effect of an interposition shunt could notbe 
tolerated. The development of ascites from the second to 
about the eighth week postoperatively was a strong indica-
tion of delayed graft thrombosis. Two dogs developed 
ascites in their second and third postoperative week, and 
both of these grafts were occluded. However, when the 
dogs were followed for more than four months, late occlu-
sion of the graft did not produce ascites. The formation of 
adequate collateral circulation was undoubtedly responsi-
ble for the animal's ability to tolerate late graft occlusion 
without ascites formation. Of four dogs that were followed 
from four to ten months, two had an open graft of the 10 
mm graft size, and two had occluded grafts of the 8 mm 
size but without ascites (Table IV). 
Ofthe three sizes of grafts used, the 10 mm graft performed 
best (Fig. 4). Only one of the eight dogs in this group 
occluded after the second postoperative week. All other 
grafts continued to remain patent for as long as ten months. 
The excellent patency rate for this group parallels that of 
our control group, which had a side-to-side portacaval 
shunt and no interposition graft. Performance of the 6 mm 
graft was very disappointing, with all animals in this group 
dying due to early graft occlusion. This graft invariably 
occluded within the first 24 hours postoperatively. 
The significance of the increasing deposition of calcium in 
the walls of the graft according to its length of implantation 
is difficult to determine. However, the presence of an 
endothelial layer certainly is encouraging because of its 
well-known ability to resist thrombus formation. With a 
large diameter PTFE graft, such a layer should lead to a 
favorable long-term patency rate. 
Patency Rate of PTFE Grafts 
According to Diameter 
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Fig. 4 
While dacron and teflon grafts used in the venous system 
have a high incidence of neo-intimal layering that narrows 
the inner lumen of the graft (8), we have not found any 
evidence of a thick intimal layer among the PTFE grafts that 
we studied microscopically. This suggests an additional 
advantage of the PTFE graft over other synthetic materials; 
however, longer follow-up studies of the PTFE graft in vivo 
wil l be necessary. 
There is little doubt that an autogenous vein interposition 
graft, such as the jugular vein, is superior to synthetic 
materials (16,17). However, if the effectiveness of the PTFE 
graft can be shown to compare favorably to that of the vein 
graft, then the PTFE graft would have an advantage in most 
clinical situations, since operative time and surgical stress 
would be reduced by eliminating the vein harvesting. 
Conclusions 
Our findings have demonstrated that the larger the size of 
the interposition graft, the better the patency rate. The 10 
mm diameter PTFE graft had a 87.5% patency rate when 
followed either on a short or longer-term basis. We there-
fore conclude that the PTFE graft performs adequately as a 
portacaval interposition shunt in the dog if a 10 mm 
diameter graft is used. 
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